On Wednesday, the House of Representatives approved a highly controversial bill that would criminalize gender transition treatments for minors, including surgeries and the administration of hormones or puberty blockers. The legislation also imposes severe penalties on medical providers, with convictions potentially resulting in up to ten years in federal prison. The measure passed narrowly, with a vote of 216 to 211, highlighting the deep partisan divide over transgender health care and the extent to which the federal government should regulate medical decisions for children. Civil rights organizations immediately condemned the legislation, describing it as one of the most extreme anti-transgender proposals ever considered by Congress. Supporters, in contrast, argued that the bill is a necessary safeguard against what they consider irreversible medical interventions performed too early in life, presenting it as a measure to protect minors from decisions with lifelong consequences.

The vote largely followed party lines, illustrating the polarization surrounding transgender health care. Democrats overwhelmingly opposed the bill, emphasizing the potential harm to vulnerable youth and families, while Republicans largely supported it, though a handful of members crossed party boundaries. The legislation faces significant hurdles in the Senate, where passage would require bipartisan backing that currently appears unlikely. Nevertheless, the House vote reflects the priorities of the chamber’s ultraconservative Republican faction and aligns closely with former President Donald Trump’s policy agenda. During debate, Republicans frequently referenced Trump’s prior campaign pledges and executive actions aimed at limiting gender-affirming care for minors, framing the bill as an effort to formalize those policies into federal law rather than relying on executive authority alone.

Republican Representative Marjorie Taylor Greene of Georgia, the chief sponsor of the bill, emerged as its most vocal advocate. Greene pressured House leadership to bring the legislation to the floor, even tying her support for a must-pass defense policy measure to its consideration. She portrayed the bill’s passage as fulfilling one of Trump’s central campaign promises. On the House floor, Greene argued that most Americans oppose major medical interventions for children regarding gender transition. She presented examples of surgeries on minors, holding up a visual aid of a child who had received such treatment, and asserted that Congress had a duty to intervene. Greene further claimed that the results of the 2024 election reflected a public mandate to end gender transition treatments for minors, using these points to justify the bill as both politically and morally necessary.

Other Republican lawmakers echoed Greene’s arguments, characterizing gender-affirming care as harmful and ideologically driven. Representative Barry Moore of Alabama accused Democrats of indoctrinating children by portraying such treatments as medically necessary, calling the interventions “child abuse.” Greene employed provocative analogies, suggesting that affirming a child’s self-identified gender was akin to indulging implausible childhood beliefs. While Greene has occasionally broken with Trump on unrelated issues and recently announced plans to leave Congress a year before her term ends, her leadership on anti-trans legislation has solidified her influence within the party’s conservative faction. Her prominent role in promoting the bill has underscored how contentious the issue of gender-affirming care for minors has become in national politics.

Democrats mounted a vigorous response, arguing that the legislation replaces medical expertise with political ideology and targets a small, vulnerable population for partisan gain. They warned that the bill intrudes on personal family decisions and could criminalize parents and doctors who follow established medical guidance. Representative Jamie Raskin of Maryland emphasized that the bill undermines parental rights by shifting decision-making authority from families and medical professionals to politicians. Representative Mark Takano of California noted that the surgeries cited by Greene are extremely rare, while the broader impact of the legislation would restrict access to medications widely considered safe and effective for transgender youth. Takano also highlighted concerns about privacy, suggesting the bill could allow investigations into medical records without improving the safety of children, potentially increasing stigma and fear among affected families.

The debate also included remarks from Representative Sarah McBride of Delaware, the first openly transgender member of Congress. McBride criticized the Republican focus on transgender issues, arguing that lawmakers were disproportionately concentrating on a small, misunderstood segment of the population—estimated at around one percent—while ignoring larger health care challenges affecting Americans more broadly. “They think more about trans people than trans people think about trans people,” McBride asserted, highlighting the perceived imbalance in legislative priorities. In the final House vote, three Democrats—Henry Cuellar and Vicente Gonzalez of Texas and Don Davis of North Carolina—joined Republicans in supporting the bill, while four Republicans—Gabe Evans of Colorado, Brian Fitzpatrick of Pennsylvania, Mike Lawler of New York, and Mike Kennedy of Utah—voted against it. The narrow passage signals that the debate over gender-affirming care for minors will remain a highly contentious issue.

Beyond this vote, Representative Greene has introduced a second bill that would prohibit Medicaid coverage for gender-affirming care for transgender youth, which is scheduled for a House vote later this week. Together, these legislative efforts illustrate the ongoing focus of certain conservative lawmakers on restricting access to medical care for transgender minors. The bills have intensified public discussion around parental rights, medical authority, and the role of government in personal health decisions. Civil rights groups continue to condemn the measures, warning that criminalizing medical care for minors could create fear and stigma while failing to address the actual well-being of transgender youth. The passage of the first bill in the House, despite its slim margin and the unlikelihood of Senate approval, underscores the deep partisan and ideological divides shaping contemporary debates over transgender rights and health care policy in the United States.